MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial

News   Oct 20, 2016

 
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial
 
 
 

RELATED ARTICLES

$2.5M Contract Awarded to ChromaTan to Develop Continuous Purification Platform

News

ChromaTan Corporation, a provider of continuous and single-use chromatography solutions for the biotechnology industry, has been awarded a $2.5M contract from the Food and Drug Administration (FDA).

READ MORE

Drug Discovery Alliance Formed to Help Increase Drug Development Success Rate

News

Two prominent preclinical safety companies have launched a unique European alliance to address the high safety-related failure rate in drug development.

READ MORE

Innovative Chromatography Technologies to be Discussed at Preconference Workshop

News

Biopharmaceutical researchers from around the globe will discuss innovative chromatographic approaches and technologies for purifying diverse biomolecules during a preconference workshop sponsored by Bio-Rad Laboratories, Inc.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE